Results

Total Results: 1,653 records

Showing results for "described".

361. serious-mental-illness-outcomes-140303 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/mental-illness-outcomes_research-protocol.pdf
     March 03, 2014 - In 2006, the Institute of Medicine (IOM) described an approach for developing, testing, and validating

362. Outcome Definition and Measurement in Observational Comparative Effectiveness Research
     effectivehealthcare.ahrq.gov/sites/default/files/outcome-definition-and-measurement-chapter-6.pptx
     January 01, 2013 - considered when developing outcome definitions for observational comparative effectiveness research studies, described … considered when developing outcome definitions for observational comparative effectiveness research studies, described … considered when developing outcome definitions for observational comparative effectiveness research studies, described

363. Disposition of Comments for Imaging Tests for the Staging of Colorectal Cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-staging_disposition-comments.pdf
     November 20, 2014 - Are the characteristics of the studies clearly described? … The estimates of test performance are explicitly described, but the report could benefit from some … Are the limitations of the review/studies described adequately? … There are implications about the need for future research, but this was not explicitly described - … The dose monitoring/reduction features described below play a significant role in helping to reduce

364. Disposition of Comments Report for Chronic Venous Ulcers: A Comparative Effectiveness Review of Treatment Modalities (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/venous-ulcers-treatment_disposition-comments.pdf
     January 27, 2014 - TEP #1 Results Yes (characteristics of the studies clearly described) Thank you for reviewing our … TEP #1 Discussion Yes (are the limitations of the review/studies described adequately) Thank you … Wound healing rates as described by Dr. … grading evaluated risk of bias, consistency, directness, and precision of the body of evidence, as described … Compression levels greater than 20 mmHg were discussed but a standard acceptable level was not described

365. Intermittent Inhalded Corticosteroids and Long-Acting Muscarinic Antagonists for Asthma (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-194-evidence-summary-corticosteroids-asthma.pdf
     October 01, 2017 - maintenance treatment of asthma in patients 6 years and older.4 The review focuses on drugs as a class, as described

366. Version 2_Risk of Reinfection From SARS-CoV-2 -- An Update of an Antibody Response Following SARS-CoV-2 Infection and Implications for Immunity: A Living Rapid Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/version-2-risk-of-reinfection-from-SARSCoV2_0.pdf
     December 31, 2022 - In March 2021, we published a living rapid review that described the humoral (antibody) response after … As described below, for the remaining (included) studies, we performed a second risk of bias assessment … Some of the considerations for each of these areas are described below: • Sampling. … In the other relatively large series, a study from Austria, five cases were described as moderate and … Was followup complete, and if not, were the reasons to loss to follow up described and explored?

367. Mental-Illness-Adults-Prisons Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/mental-illness-adults-prisons_executive.pdf
     August 01, 2013 - Our methods for judging risk of bias of individual studies are described above; we took the median … systematic reviews have been conducted on interventions for offenders with SMI; however, neither review described … Balanced Reporting of All Interventions Assessed The trials that addressed KQ1 described the treatment … The trials that addressed KQ2 described the treatment of interest in detail but provided very little … However, this conclusion is based on two trials that poorly described both the treatment and its comparator

368. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/venous-ulcers-treatment_research-protocol.pdf
     September 13, 2012 - www.effectivehealthcare.ahrq.gov Published Online: September 13, 2012 as moisturizers o At least moderate compression described … • At least moderate compression described either qualitatively or quantitatively (>20 mm), so that … • At least moderate compression described either qualitatively or quantitatively (>20 mm), so that … study (a) included at least 30 patients with chronic venous leg ulcers for at least 6 weeks; (b) described … dressings containing non-active components such as moisturizers o At least moderate compression described

369. Palliative radiation therapy for bone metastases: Update of an ASTRO Evidence-Based Guideline (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/topic-nomination-bone-metastases.pdf
     February 01, 2017 - bonemetastases should be considered for retreatment while adhering to normal tissue dosing constraints described … treatment should be considered for EBRT retreatment while adhering to normal tissue dosing constraints described … metastases should be considered for retreatment while adhering to normal tissue dosing constraints described … treatment should be considered for EBRT retreatmentwhile adhering to normal tissue dosing constraints described … Practitioners should closely adhere to quality and safety considerations for SBRT delivery as described

370. Liver-Cancer Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/liver-cancer_research-protocol.pdf
     July 24, 2013 - in the Review The criteria for inclusion and exclusion of studies will be based on the KQs and are described … We will use the inclusion criteria described in Appendix A. … Data Synthesis We will construct evidence tables identifying the study characteristics (as described … Outcomes The strength of evidence for each KQ will be assessed by one researcher for each outcome described … in the PICOTS using the approach described in the AHRQ Methods Guide for Effectiveness and Comparative

371. final Fibromyalgia CER protocol_3-31-14 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/fibromyalgia_research-protocol.pdf
     April 03, 2014 - based on the PICOTS framework outlined in Section II above, and the study-specific inclusion criteria described … of the individual RCTs that comprise each pooled analysis will be assessed per the Cochrane tool as described … 2010), narrow inclusion criteria or patient and intervention characteristics different than those described … Yes Intervention sufficiently described Partially Some of the above features. … No Intervention poorly described 6. Is the selection of the comparison group appropriate?

372. Disposition of Comments Report for Procalcitonin-Guides Antibiotic Therapy (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer78_procalcitonin_disposition_20121210.pdf
     October 05, 2012 - PR (#2) Introduction Introduction: The relevant issues are well described in the introduction. … As described in the report and detailed in the abstraction tables, 16 of the 18 RCT's were truly using … The separation of proximal, process measures and distal clinical outcomes is clearly described and … Commentator & Affiliation Section Comment Response PR (#3) Methods Data synthesis: the paragraph described … response necessary PR (#6) Discussion Conclusion Pages 63 - 66: While the research gaps enumerated, described

373. Supporting Patient and Consumer Involvement in Patient-Centered Outcomes Research (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/lavallee-text.pdf
     October 13, 2011 - Supporting Patient and Consumer Involvement in Patient-Centered Outcomes Research …

374. Slide 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cf_intro_ehc_cf_overview_1012.pdf
     October 13, 2011 - Slide 1 Community Forum Supporting Patient and Consumer Involvement in Patient-Centered Outcomes Research Danielle Lavallee AHRQ Community Forum October 13, 2011 Community Forum Community Forum Community Forum  Provide a brief overview of the Agency for Healthcare Research and Quality (AHR…

375. Automated-Entry Patient Generated Health Data for Chronic Conditions: The Evidence on Health Outcomes (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/patient-generated-health-data-protocol-chronic-conditions.pdf
     March 17, 2020 - For consistency between reports, we will use the same risk-of-bias assessment tool described in the … freely available and for which the accumulated published evidence indicates effectiveness or harm (as described … available and for which the accumulated published evidence indicates effectiveness or harm (as described

376. Future Research Needs for Treatment of Obstructive Sleep Apnea (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/sleep-apnea-treatment-future_research.pdf
     February 01, 2012 - These modifications are described in the first part of the Results section. … These dimensions and the Effective Health Care Program guidance on them were described in detail in … For each topic, we described our assumptions about the most appropriate PICOD criteria, in particular … These considerations are described as follows: • Use established metrics to measure compliance. … The patient advocates on the stakeholder panel described a demand by patients for better training,

377. Disposition of Comments Report for Strategies To Reduce Cesarean Birth in Low-Risk Women (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cesarean-birth-2010_disposition-comments.pdf
     January 01, 2010 - We included only those studies that met the inclusion criteria described in methods. … For example, rather that "periodic increases" being described as normal, it might be better to state … The characteristics of the studies are sufficiently described and key messages conveyed. … Too much of the studies was described under the subheading, then two paragraphs down went into the … Yes, the target population, audience, and key questions were described explicitly.

378. Trauma Informed Care: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/trauma-informed-care-executive-summary.pdf
     January 01, 2025 - Our findings of insufficient evidence do not mean that none of the individual interventions described

379. Disposition of Comments CER 219 Antipsychotics for the Prevention and Treatment of Delirium (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/delirium-disposition-comments.pdf
     September 03, 2019 - TEP Peer Reviewer #2 Results Well written and described. … main report: page 34 has now been edited to clarify the occurrence of NMS as follows: “The two RCTs described … We described the limitations to the body of evidence throughout the Results chapter, and footnote the … surgical parameters (e.g., operating room times, physiological changes during surgery) should be described

380. Disposition of Comments: Technical Brief 37 Prevention, Diagnosis, and Management of Opioids, Opioid Misuse, and Opioid Use Disorder in Older Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/tech-brief-37-opiod-use-adults-comments.pdf
     November 03, 2020 - Methods Reasonable methods adequately described. Key Informants well described. … The individual studies are inadequately described. … Many studies described and defined these concepts variably. … Key informants and their inputs are well described. … Each factor is set out in turn and gaps are adequately described.